On January 19, the Fifth Circuit Court of Appeals ordered that the cases of Triton and Vapetasia, two US-based vapor companies that filed petitions for review against the Food and Drug Administration (FDA), be reheard en banc. The move negates a previous 2-1 decision that sided with the agency. The FDA had previously issued marketing denial orders (MDOs) to Triton, a manufacturer of a variety of vaping products, and Vapetasia, an e-liquid brand.